Anavex Life Sciences Corp.
AVXL
$4.20
-$0.06-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.44% | 1.40% | -12.62% | -4.14% | -8.63% |
| Total Receivables | 4.33% | -1.34% | 23.12% | -73.95% | 4.41% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -7.69% | -4.24% | -36.18% | -1.27% | -23.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.10% | 1.35% | -12.56% | -5.57% | -8.50% |
|
|
|||||
| Total Current Assets | 28.10% | 1.35% | -12.56% | -5.57% | -8.50% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 28.10% | 1.35% | -12.56% | -5.57% | -8.50% |
|
|
|||||
| Total Accounts Payable | -37.89% | -36.96% | -3.67% | 53.21% | -52.56% |
| Total Accrued Expenses | -24.79% | -0.94% | -58.88% | 23.58% | 59.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | -2.90% | 0.00% | -1.54% |
| Total Other Current Liabilities | 0.00% | 0.00% | -2.90% | 0.00% | -1.54% |
| Total Current Liabilities | -28.78% | -22.03% | -33.99% | 32.40% | -14.22% |
|
|
|||||
| Total Current Liabilities | -28.78% | -22.03% | -33.99% | 32.40% | -14.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -28.78% | -22.03% | -33.99% | 32.40% | -14.22% |
|
|
|||||
| Common Stock & APIC | 7.84% | 2.96% | 0.97% | 0.01% | 0.61% |
| Retained Earnings | -1.49% | -2.64% | -3.68% | -3.22% | -3.60% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 33.47% | 4.30% | -8.82% | -10.06% | -7.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.47% | 4.30% | -8.82% | -10.06% | -7.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 33.47% | 4.30% | -8.82% | -10.06% | -7.77% |
|
|
|||||